Improvement of Cis-dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model
- 1 April 1977
- Vol. 39 (4) , 1357-1361
- https://doi.org/10.1002/1097-0142(197704)39:4<1357::aid-cncr2820390402>3.0.co;2-c
Abstract
Cis-Dichlorodiammineplatinum (CPDD) NSC 119875 was given at toxic doses (3 mg/kg) to three groups of dogs. The renal toxicity was avoided with massive prehydration and with mannitol induced diuresis. The bone marrow toxicity was unaltered by either manipulation. The data presented indicate that a better therapeutic index has been achieved by osmotic diuresis with mannitol. Blood levels and urine levels measurements show that the pharmocokinetics of the drug are unaltered, the urinary concentration of drug being low in the first few hours, but with similar urinary drug recovery in all three groups.This publication has 4 references indexed in Scilit:
- Mercury‐Induced Renal Vascular Shut‐Down: Observations in Experimental Acute Renal FailureEuropean Journal of Clinical Investigation, 1974
- cis-Dichlorodiammineplatinum(II) (NSC-119 875): Preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and miceToxicology and Applied Pharmacology, 1973
- Metabolism of platinum [14cethylenediamine dichloride in the ratBiochemical Pharmacology, 1973
- Antileukaemic and Nephrotoxic Properties of Platinum CompoundsNature, 1971